跳至主要内容
临床试验/ISRCTN87452036
ISRCTN87452036已完成不适用

Effect of amitriptyline on dyspeptic symptoms assessed with the drink test in patients with functional dyspepsia

Academic Medical Centre (AMC) (The Netherlands)0 个研究点目标入组 100 人开始时间: 2005年8月4日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Nepean Dyspepsia Index (NDI) score greater than or equal to 25
  • 2. No depression according to Zung questionnaire
  • 3. Aged greater than 18 and less than 65 years
  • 4. Drugs known to affect gastrointestinal (GI) motility should be stopped at least 24 hours prior to the study

排除标准

  • 1. Reflux-like dyspepsia (Rome II criteria)
  • 2. Unable to stop drug intake (see inclusion criteria)
  • 3. Use of tricyclic antidepressants
  • 4. Organic abnormalities explaining the dyspeptic complaints encountered during endoscopy or abdominal ultrasound
  • 5. Epilepsy
  • 6. Organic brain damage
  • 7. Urine retention
  • 8. Prostatic hyperplasia
  • 9. Pyloric stenosis
  • 10. Cardiovascular disorders
  • 11. Hyperthyroidism, liver- and kidney-function disorders

研究者

发起方
Academic Medical Centre (AMC) (The Netherlands)

相似试验